A cross-sectional study of enterovirus nucleic acid test with throat swabs for term late neonates during coronavirus disease 2019
SHI Ming-Rui, XU Hai-Dong, WANG Hong, HEI Ming-Yan
National Center for Children's Health/Neonatal Center, Beijing Children's Hospital, Capital Medical University, Beijing 100045, China (Hei M-Y, Email: heimingyan@bch.com.cn)
Abstract：Objective To investigate the positive rate of enterovirus (EV) nucleic acid in throat swabs of term late neonates hospitalized during the coronavirus disease 2019 (COVID-19) epidemic and the clinical characteristics of the neonates. Methods A single-center cross-sectional study was performed on 611 term late infants who were hospitalized in the neonatal center from October 2020 to September 2021. Throat swabs were collected on admission for coxsackie A16 virus/EV71/EV universal nucleic acid testing. According to the results of EV nucleic acid test, the infants were divided into a positive EV nucleic acid group (8 infants) and a negative EV nucleic acid group (603 infants). Clinical features were compared between the two groups. Results Among the 611 neonates, 8 tested positive for EV nucleic acid, with a positive rate of 13.1‰, among whom 7 were admitted from May to October. There was a significant difference in the proportion of infants contacting family members with respiratory infection symptoms before disease onset between the positive and negative EV nucleic acid groups (75.0% vs 10.9%, P<0.001). There were no significant differences between the two groups in demographic data, clinical symptoms, and laboratory test results (P>0.05). Conclusions There is a certain proportion of term late infants testing positive for EV nucleic acid in throat swabs during the COVID-19 epidemic, but the proportion is low. The clinical manifestations and laboratory test results of these infants are non-specific. Transmission among family members might be an important cause of neonatal EV infection. Citation:Chinese Journal of Contemporary Pediatrics, 2023, 25(4): 339-343
SHI Ming-Rui,XU Hai-Dong,WANG Hong et al. A cross-sectional study of enterovirus nucleic acid test with throat swabs for term late neonates during coronavirus disease 2019[J]. CJCP, 2023, 25(4): 339-343.
Cordey S, Schibler M, L'Huillier AG, et al. Comparative analysis of viral shedding in pediatric and adult subjects with central nervous system-associated enterovirus infections from 2013 to 2015 in Switzerland[J]. J Clin Virol, 2017, 89: 22-29. PMID: 28214758. DOI: 10.1016/j.jcv.2017.01.008.
Khetsuriani N, Lamonte A, Oberste MS, et al. Neonatal enterovirus infections reported to the national enterovirus surveillance system in the United States, 1983-2003[J]. Pediatr Infect Dis J, 2006, 25(10): 889-893. PMID: 17006282. DOI: 10.1097/01.inf.0000237798.07462.32.
Cabrerizo M, Díaz-Cerio M, Mu?oz-Almagro C, et al. Molecular epidemiology of enterovirus and parechovirus infections according to patient age over a 4-year period in Spain[J]. J Med Virol, 2017, 89(3): 435-442. PMID: 27505281. DOI: 10.1002/jmv.24658.
Lv XQ, Qian LH, Wu T, et al. Enterovirus infection in febrile neonates: a hospital-based prospective cohort study[J]. J Paediatr Child Health, 2016, 52(8): 837-841. PMID: 27149142. DOI: 10.1111/jpc.13193.
Lafolie J, Labbé A, L'Honneur AS, et al. Assessment of blood enterovirus PCR testing in paediatric populations with fever without source, sepsis-like disease, or suspected meningitis: a prospective, multicentre, observational cohort study[J]. Lancet Infect Dis, 2018, 18(12): 1385-1396. PMID: 30389482. PMCID: PMC7164799. DOI: 10.1016/S1473-3099(18)30479-1.
Cortese F, Scicchitano P, Gesualdo M, et al. Early and late infections in newborns: where do we stand? A review[J]. Pediatr Neonatol, 2016, 57(4): 265-273. PMID: 26750406. DOI: 10.1016/j.pedneo.2015.09.007.
Belov Y, Many A, Givon I, et al. Maternal presentation and neonatal outcome in peripartum enterovirus infection[J]. Acta Paediatr, 2021, 110(5): 1483-1489. PMID: 33251624. DOI: 10.1111/apa.15703.
Izumita R, Deuchi K, Aizawa Y, et al. Intrafamilial transmission of parechovirus a and enteroviruses in neonates and young infants[J]. J Pediatric Infect Dis Soc, 2019, 8(6): 501-506. PMID: 30184210. DOI: 10.1093/jpids/piy079.
Chang LY, Tsao KC, Hsia SH, et al. Transmission and clinical features of enterovirus 71 infections in household contacts in Taiwan[J]. JAMA, 2004, 291(2): 222-227. PMID: 14722149. DOI: 10.1001/jama.291.2.222.
Abzug MJ, Michaels MG, Wald E, et al. A randomized, double-blind, placebo-controlled trial of pleconaril for the treatment of neonates with enterovirus sepsis[J]. J Pediatric Infect Dis Soc, 2016, 5(1): 53-62. PMID: 26407253. PMCID: PMC4765488. DOI: 10.1093/jpids/piv015.
Torres-Torres S, Myers AL, Klatte JM, et al. First use of investigational antiviral drug pocapavir (v-073) for treating neonatal enteroviral sepsis[J]. Pediatr Infect Dis J, 2015, 34(1): 52-54. PMID: 25229269. DOI: 10.1097/INF.0000000000000497.
Raouf M, El-Din OS, Khadr NA, et al. Clinical and laboratory detection of nonpolio enteroviruses among different age groups of aseptic meningitis patients in Alexandria, Egypt[J]. J Med Virol, 2021, 93(6): 3389-3396. PMID: 32880992. DOI: 10.1002/jmv.26480.
